Aidoc has announced strategic partnerships with Cercare Medical and Circle Cardiovascular Imaging (CVI) to expand its neurosciences portfolio with advanced magnetic resonance (MR) perfusion and automated Alberta stroke programme early computed tomography score (ASPECTS). These partnerships are set to advance Aidoc’s mission to connect “fragmented” neuro workflows and accelerate high‑stakes decisions, according to a recent press release from the company.
The US Food and Drug Administration (FDA)‑cleared and CE-marked partner algorithms will be fully integrated into aiOS—Aidoc’s enterprise operating system for clinical artificial intelligence (AI), which enables efficient AI deployment, customisable and seamless workflows for neuro teams, and robust outcome measurement.
Aidoc claims that its comprehensive neurosciences suite comprises radiology and mobile care coordination solutions for intracranial haemorrhage, vessel occlusions, CT perfusion, c-spine fractures, vertebral compression fractures and brain aneurysms, and expanding capabilities to include MR perfusion and automated ASPECTS will “empower consistent, data‑driven decisions from first image through intervention”, and streamline workflows across neurology, neuroradiology, neurointervention and neurosurgery.
“Our mission at Aidoc is to empower every neuro discipline by connecting fragmented workflows and accelerating critical decisions,” said Tom Valent, chief business officer at Aidoc. “These strategic partnerships with Cercare Medical and Circle CVI are pivotal to that commitment. By integrating their specialised expertise in MR perfusion and ASPECTS, we’re not just adding features; we’re deepening our clinical insights and expanding the reach of AI to drive superior outcomes for patients with stroke and other complex neurological conditions.”
The aforementioned collaboration with Cercare will bring advanced MR perfusion capabilities to the aiOS platform. According to Aidoc’s recent release, MR perfusion provides crucial physiological information about blood flow in the brain that is essential for identifying salvageable tissue in extended-window stroke patients and characterising brain tumours. Cercare’s innovative metabolic perfusion solutions—which deliver high-quality perfusion maps based on proprietary biomarkers—will enable more precise and timely insights for neuro teams, the release adds.
“Partnering with Aidoc allows us to bring our advanced MR perfusion technology to a broader clinical audience through a unified, intelligent platform,” commented Henrik Andersen, chief commercial officer at Cercare. “This collaboration combines powerful imaging biomarkers with scalable AI integration, enhancing neurodiagnostic workflows and supporting faster, more informed treatment decisions for complex patient cases.”
Additionally, Aidoc says its partnership with Circle CVI will integrate the latter company’s expertise in automated ASPECTS—a critical tool for rapidly assessing early ischaemic changes on CT scans in acute stroke. Circle CVI’s robust, automated approach to ASPECTS will provide consistent and objective quantification, streamlining triage and improving inter-physician communication, the release states.
“Our collaboration with Aidoc is a testament to the power of integrating specialised AI,” said Erkan Akyuz, chief executive officer (CEO) of Circle CVI. “By embedding our automated ASPECTS into Aidoc’s comprehensive platform, we can help more stroke teams achieve faster, more reliable assessments, ultimately impacting patient pathways positively.”
